Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTOPHER ROBERT DANGELO

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1629416409
CMS profile
380983
Location
OMAHA, NE

General Payments · PY2021–2024

$41,232.18

  • Reported across 81 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$11,948.36

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Genmab U.S., Inc. $4,483.72 11
E.R. Squibb & Sons, L.L.C. $2,091.00 2
BeiGene USA, Inc. $2,085.73 3
ABBVIE INC. $1,865.84 5
Acerta Pharma LLC $519.63 5
ADC Therapeutics America, Inc. $321.88 3
TAIHO ONCOLOGY, INC. $260.75 4
Celgene Corporation $248.18 3
Genentech USA, Inc. $71.63 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $3,204.88 9
PY2022 $12,986.69 18
PY2023 $13,092.25 17
PY2024 $11,948.36 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $550.00 02/16/2024 Consulting Fee Undisputed 01/23/2026 1103133371 CMS
ABBVIE INC. $550.00 08/06/2024 Consulting Fee Undisputed 01/23/2026 1103133373 CMS
ABBVIE INC. $124.17 12/06/2024 Food and Beverage Undisputed 01/23/2026 1103525680 CMS
ABBVIE INC. $275.00 12/19/2024 Consulting Fee Undisputed 01/23/2026 1103133375 CMS
ABBVIE INC. $366.67 12/23/2024 Consulting Fee Undisputed 01/23/2026 1103133377 CMS
ADC Therapeutics America, Inc. $49.60 07/15/2024 Food and Beverage Undisputed 01/23/2026 1121192947 CMS
ADC Therapeutics America, Inc. $122.28 08/09/2024 Food and Beverage Undisputed 01/23/2026 1121192961 CMS
ADC Therapeutics America, Inc. $150.00 12/08/2024 Food and Beverage Undisputed 01/23/2026 1121193007 CMS
AstraZeneca Pharmaceuticals LP $72.55 08/06/2024 Travel and Lodging Undisputed 01/23/2026 1104257181 CMS
AstraZeneca Pharmaceuticals LP $290.70 09/30/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1104571252 CMS
AstraZeneca Pharmaceuticals LP $20.51 09/30/2024 Food and Beverage Undisputed 01/23/2026 1104624018 CMS
AstraZeneca Pharmaceuticals LP $75.87 10/31/2024 Travel and Lodging Undisputed 01/23/2026 1105606367 CMS
AstraZeneca Pharmaceuticals LP $60.00 12/08/2024 Food and Beverage Undisputed 01/23/2026 1105627419 CMS
BeiGene USA, Inc. $1,950.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1120856771 CMS
BeiGene USA, Inc. $52.24 12/07/2024 Food and Beverage Undisputed 01/23/2026 1120856769 CMS
BeiGene USA, Inc. $83.49 12/09/2024 Food and Beverage Undisputed 01/23/2026 1120856767 CMS
Celgene Corporation $135.00 07/15/2024 Food and Beverage Undisputed 01/23/2026 1101181358 CMS
Celgene Corporation $51.19 07/15/2024 Food and Beverage Undisputed 01/23/2026 1101181360 CMS
Celgene Corporation $61.99 07/15/2024 Travel and Lodging Undisputed 01/23/2026 1101181364 CMS
E.R. Squibb & Sons, L.L.C. $2,076.00 08/08/2024 Consulting Fee Undisputed 01/23/2026 1101750647 CMS
E.R. Squibb & Sons, L.L.C. $15.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 1101750702 CMS
Genentech USA, Inc. $71.63 12/07/2024 Food and Beverage Undisputed 01/23/2026 1132989078 CMS
Genmab U.S., Inc. $78.85 04/19/2024 Travel and Lodging Undisputed 01/23/2026 1126825431 CMS
Genmab U.S., Inc. $258.77 04/19/2024 Travel and Lodging Undisputed 01/23/2026 1126825441 CMS
Genmab U.S., Inc. $898.96 04/19/2024 Travel and Lodging Undisputed 01/23/2026 1126825443 CMS
Genmab U.S., Inc. $33.54 04/20/2024 Food and Beverage Undisputed 01/23/2026 1126825433 CMS
Genmab U.S., Inc. $23.96 04/20/2024 Food and Beverage Undisputed 01/23/2026 1126825435 CMS
Genmab U.S., Inc. $47.92 04/20/2024 Food and Beverage Undisputed 01/23/2026 1126825439 CMS
Genmab U.S., Inc. $48.00 04/21/2024 Travel and Lodging Undisputed 01/23/2026 1126825437 CMS
Genmab U.S., Inc. $2,925.00 05/09/2024 Consulting Fee Undisputed 01/23/2026 1126825445 CMS
Genmab U.S., Inc. $21.30 07/16/2024 Food and Beverage Undisputed 01/23/2026 1126825447 CMS
Genmab U.S., Inc. $89.41 12/09/2024 Food and Beverage Undisputed 01/23/2026 1126825449 CMS
Genmab U.S., Inc. $58.01 12/09/2024 Food and Beverage Undisputed 01/23/2026 1126825451 CMS
TAIHO ONCOLOGY, INC. $40.69 08/06/2024 Travel and Lodging Undisputed 01/23/2026 1137940952 CMS
TAIHO ONCOLOGY, INC. $163.04 09/30/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1137936377 CMS
TAIHO ONCOLOGY, INC. $11.50 09/30/2024 Food and Beverage Undisputed 01/23/2026 1137937515 CMS
TAIHO ONCOLOGY, INC. $45.52 10/31/2024 Travel and Lodging Undisputed 01/23/2026 1137942328 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.